Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00721123 · BASELINE

Baseline characteristics

A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis · Source last updated 2013-11-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      538
    units
    Participants
groups
  1. description
    Patients received tocilizumab 8 mg/kg intravenously every 4 weeks.
    id
    BG000
    title
    Tocilizumab 8 mg/kg
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          12.03
          value
          50.8
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          443
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          95
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
All-exposure population: All patients who entered the study and received at least one dose of tocilizumab at any time. Baseline was defined as the first dose of study drug, whether that occurred in the WA17822 study or the WA18695 study.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      538
    units
    Participants
groups
  1. description
    Patients received tocilizumab 8 mg/kg intravenously every 4 weeks.
    id
    BG000
    title
    Tocilizumab 8 mg/kg
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          12.03
          value
          50.8
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          443
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          95
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
population Description
All-exposure population: All patients who entered the study and received at least one dose of tocilizumab at any time. Baseline was defined as the first dose of study drug, whether that occurred in the WA17822 study or the WA18695 study.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice